Use of Engineered Stem Cells Derived from Skin to Treat Triple Negative Breast Cancer
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Falcon Therapeutics, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Karen Giroux
Fiscal Year
2018
Region
Research Triangle
Project Description:
In collaboration with scientists at UNC-Chapel Hill, Falcon Therapeutics Inc has pioneered the development of engineered neural stem cells derived from patient skin biopsies, that seek out and destroy cancer cells without expected side effects. This new approach will be applied to Triple Negative Breast Cancer, a disease with few treatment options.